retatrutide clinical trial results weight loss 2024 2025 press release Lilly's triple agonist, retatrutide, delivered powerful in pivotal Phase 3 obesity retatrutide clinical trial results 2024
Pay in 4 interest-free payments of $5.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29



























